DARATUMUMAB, A CD38 MONOCLONAL ANTIBODY STUDY IN ADVANCED MULTIPLE MYELOMA - AN OPEN-LABEL, DOSE ESCALATION FOLLOWED BY OPEN-LABEL EXTENSION IN A SINGLE-ARM PHASE I/II STUDY

被引：0
|
作者：
Lokhorst, H. [1 ]
Plesner, T. [2 ]
Gimsing, P. [3 ]
Nahi, H. [4 ]
Lisby, S. [5 ]
Richardson, P. [6 ]
机构：
[1] Univ Med Ctr Utrecht, Utrecht, Netherlands
[2] Vejie Hosp, Vejie, Denmark
[3] Copenhagen Univ Hosp, Copenhagen, Denmark
[4] Karolinska Univ Hosp, Stockholm, Sweden
[5] Genmab A S, Copenhagen, Denmark
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S576
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [31] Open-label, single-arm phase Ib/II study of immune combination therapy with elotuzumab and belantamab mafodotin in patients with relapsed refractory multiple myeloma
    Browning, Sabrina
    Li, Fangyong
    Parker, Terri L.
    Bar, Noffar
    Anderson, Tara
    Stevens, Erica
    VanOudenhove, Jennifer
    Matthews, Martin
    Gorshein, Elan
    Talsania, Ashita D.
    Sabbath, Kert D.
    Seropian, Stuart
    Halene, Stephanie
    Neparidze, Natalia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] Pharmacokinetic and pharmacodynamic properties of ciprofol emulsion in Chinese subjects: a single center, open-label, single-arm dose-escalation phase 1 study
    Teng, Yi
    Ou, Meng-Chan
    Wang, Xiao
    Zhang, Wen-Sheng
    Liu, Xiao
    Liang, Yong
    Zuo, Yun-Xia
    Zhu, Tao
    Liu, Bin
    Liu, Jin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (12): : 13791 - 13802
  • [33] An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma
    Kanai, Fumihiko
    Obi, Shuntaro
    Fujiyama, Shigetoshi
    Shiina, Shuichiro
    Tamai, Hideyuki
    Mochizuki, Hitoshi
    Koike, Yukihiro
    Imamura, Jun
    Yamaguchi, Takayoshi
    Saida, Isamu
    Yokosuka, Osamu
    Omata, Masao
    HEPATOLOGY INTERNATIONAL, 2014, 8 (01) : 94 - 103
  • [34] An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma
    Fumihiko Kanai
    Shuntaro Obi
    Shigetoshi Fujiyama
    Shuichiro Shiina
    Hideyuki Tamai
    Hitoshi Mochizuki
    Yukihiro Koike
    Jun Imamura
    Takayoshi Yamaguchi
    Isamu Saida
    Osamu Yokosuka
    Masao Omata
    Hepatology International, 2014, 8 : 94 - 103
  • [35] mFOLFOX6+bevacizumab + PD-1 monoclonal antibody in locally advanced MSS CRC (BASKETII): A prospective, single-arm, open-label, phase II study
    Huang, J.
    He, W.
    Zhao, Y.
    He, F.
    Liu, Z.
    Pei, F.
    Yao, Q.
    ANNALS OF ONCOLOGY, 2024, 35 : S1433 - S1433
  • [36] Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A
    Taylor, Claribel P.
    Tummala, Sanjeev
    Molrine, Deborah
    Davidson, Lisa
    Farrell, Richard J.
    Lembo, Anthony
    Hibberd, Patricia L.
    Lowy, Israel
    Kelly, Ciaran P.
    VACCINE, 2008, 26 (27-28) : 3404 - 3409
  • [37] Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumors
    Minami, Hironobu
    Ando, Yuichi
    Ma, Brigette Buig Yue
    Lee, Jih-Hsiang
    Momota, Hiroyuki
    Fujiwara, Yutaka
    Li, Leung
    Fukino, Koichi
    Ito, Koji
    Tajima, Takeshi
    Mori, Asuka
    Lin, Chia-Chi
    CANCER SCIENCE, 2016, 107 (10) : 1477 - 1483
  • [38] Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
    Tsuyoshi Matsumura
    Hiroya Hashimoto
    Masahiro Sekimizu
    Akiko M. Saito
    Yasufumi Motoyoshi
    Akinori Nakamura
    Satoshi Kuru
    Takayasu Fukudome
    Kazuhiko Segawa
    Toshiaki Takahashi
    Takuhisa Tamura
    Tetsuo Komori
    Chigusa Watanabe
    Masanori Asakura
    Koichi Kimura
    Yuko Iwata
    Orphanet Journal of Rare Diseases, 17
  • [39] Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
    Matsumura, Tsuyoshi
    Hashimoto, Hiroya
    Sekimizu, Masahiro
    Saito, Akiko M.
    Motoyoshi, Yasufumi
    Nakamura, Akinori
    Kuru, Satoshi
    Fukudome, Takayasu
    Segawa, Kazuhiko
    Takahashi, Toshiaki
    Tamura, Takuhisa
    Komori, Tetsuo
    Watanabe, Chigusa
    Asakura, Masanori
    Kimura, Koichi
    Iwata, Yuko
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [40] A single-arm, open-label, multicenter study of tranilast for advanced heart failure in patients with muscular dystrophy
    Matsumura, T.
    Hashimoto, H.
    Sekimizu, M.
    Saito, A.
    Asakura, M.
    Kimura, K.
    Iwata, Y.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S103 - S103
12345